Neway provides a value‑based care stewardship program for dialysis clinics that optimizes lab order sets to maximize revenue, reduce unnecessary testing, and ensure compliance with CMS guidelines.
Funding
$134K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Dialysis clinics often face high laboratory fees and inconsistent revenue due to inefficient order sets, non‑compliant testing, and delayed lab results, which can impede patient care and financial performance.
Solution
Neway offers a value‑based care stewardship program that partners with Quest Diagnostics to provide next‑day lab results and robust emergency‑preparedness logistics. The program reviews and optimizes dialysis lab order sets to align with CMS guidelines, eliminating wasteful testing and increasing lab revenue. Its eLabs Platform integrates with dialysis‑specific EMRs, automating ordering, reporting, and clinical decision support while delivering real‑time alerts and secure data handling. By streamlining workflows and ensuring specimen integrity, Neway helps clinics achieve faster, more reliable lab turnaround and better cost‑of‑care control.
Target Audience
Primary customers are dialysis clinics and ESRD programs seeking to improve lab revenue, reduce testing costs, and enhance patient care efficiency.
Features
- Optimized lab order set design that maximizes revenue and reduces unnecessary testing in compliance with CMS regulations
- Partnership with Quest Diagnostics for next‑day result delivery and specimen logistics that preserve sample integrity
- eLabs Platform® with user‑friendly interface, real‑time critical alerts, dashboards, and draw calendars
- Seamless EMR integration that auto‑syncs patient data, KT/V calculations, and lab results bidirectionally
- Built‑in clinical decision support tools for disease management, including hepatitis protocol guidance
- Enterprise‑grade cyber security ensuring HIPAA‑compliant protection of PHI